Temapharm SRL
The score of Temapharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +174 % Total assets +14 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Temapharm's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 84,991 € | ||||
| Equity | 71,330 € | ||||
| Cash | 32,479 € | ||||
| EBITDA | 123,712 € | ||||
| Total assets | 191,548 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Jun 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 23 Jun 2023
- Year ended 31 Dec 2021filed on 18 Aug 2022
Temapharm's financial analysis
- Solvency37.2%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Temapharm
Temapharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0727.468.425
- VAT number
- BE0727468425
- Peppol
- Registered · 0208:0727468425 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 May 2019
- Registered office
- 4121 Neupré
- Latest accounts
- 2025 · filed on 25 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Temapharm (SRL) has been based in Neupré since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 84,991 € and equity of 71,330 €; its revenue is not published. Its solvency stands at 37.2%, below the median of its sector (41.5%).
Companies similar to Temapharm
Companies in the same business, of comparable size and area, outside its group.
- OVUM Bxl Public relations and communication activities Uccle · balance sheet 776,837 €
- ACP-Pharma Retail sale of pharmaceutical products Affligem · balance sheet 48,017 €
- Pogge Retail sale of pharmaceutical products Schaerbeek · balance sheet 285,910 €
- Antha Consult Retail sale of pharmaceutical products Liège · balance sheet 272,102 €
- LEND Retail sale of pharmaceutical products Herent · balance sheet 168,624 €
- Farmacyze Retail sale of pharmaceutical products Ostend · balance sheet 73,863 €
- Apotheek Veramme - Casier Retail sale of pharmaceutical products Wetteren · balance sheet 614,611 €
- Pharm'Training Lab Retail sale of pharmaceutical products Leuze-en-Hainaut · balance sheet 87,540 €
Frequently asked questions about Temapharm
What is the revenue of Temapharm?
Temapharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Temapharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0727468425 for Temapharm, if the company is VAT-registered. Its company number (CBE) is 0727.468.425.
Where is the registered office of Temapharm?
According to the CBE register, the registered office of Temapharm is in 4121 Neupré.
What is the equity of Temapharm?
At the close of the 2025 financial year, the equity of Temapharm amounts to 71,330 €, a solvency of 37.2% of total assets.
Who manages Temapharm?
The register lists 2 active mandates at Temapharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Temapharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →